Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial - Wikidata - awgldk - TriplyDB

Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial

Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial

http://www.wikidata.org/entity/Q28177059

about

Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment Childhood obesity A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion The measurement of health-related quality of life (QOL) in paediatric clinical trials: a systematic review Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity Intervention Neuroendocrine Disorders in Pediatric Craniopharyngioma Patients Endocrinopathies in survivors of childhood neoplasia Energy balance and metabolism after cancer treatment Weight gain in craniopharyngioma--a model for hypothalamic obesity Evaluation and Treatment of Severe Obesity in Childhood.A novel rodent model that mimics the metabolic sequelae of obese craniopharyngioma patients Recruitment feasibility to a cohort study of endocrine and metabolic health among survivors of childhood brain tumours: a report from the Canadian study of Determinants of Endometabolic Health in ChIlDrEn (CanDECIDE).Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical data Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index An evolving scientific basis for the prevention and treatment of pediatric obesity Hyperphagia: current concepts and future directions proceedings of the 2nd international conference on hyperphagia Somatostatin and cancer: applying endocrinology to oncology.Current and investigational antiobesity agents and obesity therapeutic treatment targets.Pharmacological treatment of obesity in children and adolescents: present and future Obesity Prevention for Children with Developmental Disabilities.Overweight and obesity in children and adolescents Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children Genetics of childhood obesity Obesity and craniopharyngioma.The therapeutic potential of somatostatin receptor ligands in the treatment of obesity and diabetes.Effects of octreotide on glucose transporter type 2 expression in obese rat small intestine.Pediatric obesity: etiology and treatment.Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats.Effects of methylphenidate on weight gain and food intake in hypothalamic obesity.Diagnostics, treatment, and follow-up in craniopharyngioma.Current strategies in diagnostics and endocrine treatment of patients with childhood craniopharyngioma during follow-up--recommendations in KRANIOPHARYNGEOM 2000.Malnutrition and obesity in pediatric oncology patients: causes, consequences, and interventions.Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity.Insulin resistance, hyperinsulinemia, and energy intake in overweight children Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery.Somatostatin receptor expression and biological functions in endocrine pancreatic cells: review based on a doctoral thesis.Canadian Study of Determinants of Endometabolic Health in ChIlDrEn (CanDECIDE study): a cohort study protocol examining the mechanisms of obesity in survivors of childhood brain tumours Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up.Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity Parent-perceived child cognitive function: results from a sample drawn from the US general population.

P2860

Q21131286-2FA7545B-C8CF-490B-B963-7CC8E905ED5A Q24620970-1587F479-C18A-4EE2-AB9C-1A60D8FDC232 Q24678786-33FB2840-D6C2-452E-9FD2-8A99D5A850DB Q24799973-136B55AE-443B-418C-A032-242D4CBF8CE1 Q26786921-8AD040D7-876E-4AB5-9D85-B69F8C06947C Q26799613-4A8F6174-D4B5-4782-9469-A28888861969 Q27009171-C433FB0A-3367-4B68-AA6F-C4506903FBCE Q27015118-B369A421-CA3F-4B59-9594-F551FC6A6025 Q28303668-48C38E04-3A1F-4553-977A-C8C313C0B5ED Q30300992-E6ED3D80-FD54-48B3-AB1E-76EBD5ECF925 Q30418917-54DB605A-3B03-46E3-876A-59478C009B23 Q30582316-4DAE3FCF-1723-45BD-AC60-8B952911D263 Q31144148-2D6E2366-0F2D-4E04-B3C5-DFFF6B99D0C6 Q33426110-D26FB1C9-A473-4CC7-89A8-FB2799B25B22 Q34028763-676CD235-F6CE-4628-A4B3-A45444E15DD3 Q34158925-8B5D8702-6572-4720-A8FB-8F0980ED33F3 Q34181921-BBC313B6-496A-4BFB-BFDF-7A7008D4327B Q34344786-D94E6D0F-FC3D-42DC-B48A-F806D3DEC7B5 Q34442880-6871882A-9B88-4132-BD8F-286CC3846399 Q34711543-9060FF6F-237A-48EE-A6EC-7ACC9275F2B8 Q34948884-D3F91425-9B4E-4922-B2D6-536FA865DCD0 Q34997528-723C58EE-7BF5-4B52-85AB-C3583B127F57 Q35104978-8EEFD0C5-A157-459E-A91A-339AC03687FC Q35207101-D7D7F2D6-8BE8-4510-9F45-7FE42B188003 Q35207618-F4E3B788-2929-45B8-BECA-971F6DE2BF86 Q35555748-EEF6ECCE-7438-4184-B380-1CB4AE418B35 Q35678445-FF75AA3C-B996-46AE-AB55-D7426DC61912 Q35965770-FD209524-7350-40D5-8238-774B2620A8ED Q35971177-6654E3D0-068F-485D-8DB4-EF841A4C36B8 Q35971790-2BA9937A-D5CB-494A-903B-B09B47274F44 Q36072756-180CE431-EB47-4FDD-B10B-5CEF5B50AE74 Q36309946-DCC6DC55-46AB-49BB-A80B-E1E93127359D Q36429199-733186DC-9AF0-4A04-B7C3-0E0FB7AAFA98 Q36512721-421DFC9A-7AA9-4138-94CE-B255E2F12AC1 Q36810360-06ADD531-3023-40B6-85DC-FF368463C6B3 Q36853311-E5B658A6-0F09-4727-A061-E9042468DF63 Q36939200-FA2C5CF5-C818-4356-AAA4-767114820D8A Q37060191-90CAA4D3-954B-45D7-8057-B3C43B76A6B1 Q37268906-404C9F5B-7E43-4FA7-8447-AD55FC88198C Q37452874-CBF60601-B430-4B38-8565-1B678C008615

P2860

Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial

http://www.wikidata.org/entity/Q28177059

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Octreotide therapy of pediatri ...... lind, placebo-controlled trial

@ast

Octreotide therapy of pediatri ...... lind, placebo-controlled trial

@en

Octreotide therapy of pediatri ...... lind, placebo-controlled trial

@nl

type

label

Octreotide therapy of pediatri ...... lind, placebo-controlled trial

@ast

Octreotide therapy of pediatri ...... lind, placebo-controlled trial

@en

Octreotide therapy of pediatri ...... lind, placebo-controlled trial

@nl

prefLabel

Octreotide therapy of pediatri ...... lind, placebo-controlled trial

@ast

Octreotide therapy of pediatri ...... lind, placebo-controlled trial

@en

Octreotide therapy of pediatri ...... lind, placebo-controlled trial

@nl

P1433

Q28177059-1831E781-5991-4049-AE48-276A00298163

P1476

Q28177059-DF6E1784-7732-488B-B4CC-B76EE7695A0B

P2093

Q28177059-01E00D8E-D882-4282-BDE4-106CBA8056E5

Q28177059-82140437-772D-4D40-8870-7CAC76065D76

Q28177059-873309D4-4D8F-485D-9A90-84469D90E57F

Q28177059-8FF29F1C-74B1-4283-815B-B9E74C0F79E1

Q28177059-9C1290C6-80F7-4BD4-B6E8-EE7D7FCA4619

Q28177059-B414437C-F2CF-4CDE-8464-CD0A35346519

Q28177059-C3D24A8C-C089-46D1-A4C1-8B53611D8A3E

Q28177059-D80A8C4F-4AA6-4D53-96C5-10C4338B82CC

Q28177059-ED9466A6-034B-4511-973B-E8C78D9139E0

P304

Q28177059-48CCDE5A-C103-4AB2-B1D9-19122A55ACAB

P31

Q28177059-53D7AF8B-DAB5-4F53-A716-A055635AFA11

P3181

Q28177059-D7960544-D654-4630-B71A-18304179CA84

P356

Q28177059-7DBAC589-5721-45A7-B472-864FAD911507

P407

Q28177059-49861C43-74E7-4ABB-8A12-0F2A9F239FC5

P433

Q28177059-BADE90E7-9EA5-41B6-85C6-432BED91FCED

P478

Q28177059-70E5A83C-C3A1-48C7-AD08-7A2345989F7A

P50

Q28177059-e8dd882a-4d16-3dc7-d60d-84d08213680b

P577

Q28177059-14CC7A9D-C533-4921-AD03-044CCB7CA700

P5875

Q28177059-41D4D090-5CAA-4784-B445-4D2DFD26C12B

P698

Q28177059-1607E1DE-3B6D-43BC-9892-63E20AF88478

P921

Q28177059-686D0F11-DC21-470D-99CA-CF4241492B71

Q28177059-EE183C85-7EE2-404F-88A4-E2EA91080BF6

P3181

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Octreotide therapy of pediatri ...... lind, placebo-controlled trial

@en

P2093

Karen Ringwald-Smith

http://www.w3.org/2001/XMLSchema#string

Randi E Schreiber

http://www.w3.org/2001/XMLSchema#string

Robbin K Christensen

http://www.w3.org/2001/XMLSchema#string

Robert H Lustig

http://www.w3.org/2001/XMLSchema#string

Shelly Y Lensing

http://www.w3.org/2001/XMLSchema#string

Shengjie Wu

http://www.w3.org/2001/XMLSchema#string

Shesh N Rai

http://www.w3.org/2001/XMLSchema#string

Sue C Kaste

http://www.w3.org/2001/XMLSchema#string

Xiaoping Xiong

http://www.w3.org/2001/XMLSchema#string

P304

2586-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

5110449

http://www.w3.org/2001/XMLSchema#string

P356

10.1210/JC.2002-030003

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

Pamela S. Hinds

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10723326

http://www.w3.org/2001/XMLSchema#string

P698

12788859

http://www.w3.org/2001/XMLSchema#string

P921